The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care
Open accessAbstract
Drug-resistant TB (DR-TB) remains a significant challenge in TB treatment and control programmes worldwide. Advances in sequencing technology have significantly increased our understanding of the mechanisms of resistance to anti-TB drugs. This review provides an update on advances in our understanding of drug resistance mechanisms to new, existing drugs and repurposed agents. Recent advances in WGS technology hold promise as a tool for rapid diagnosis and clinical management of TB. Although the standard approach to WGS of Mycobacterium tuberculosis is slow due to the requirement for organism culture, recent attempts to sequence directly from clinical specimens have improved the potential to diagnose and detect resistance within days. The introduction of new databases may be helpful, such as the Relational Sequencing TB Data Platform, which contains a collection of whole-genome sequences highlighting key drug resistance mutations and clinical outcomes. Taken together, these advances will help devise better molecular diagnostics for more effective DR-TB management enabling personalized treatment, and will facilitate the development of new drugs aimed at improving outcomes of patients with this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
Interaction of antibiotics with functional sites in 16S ribosomal RNA
Moazed, D., & Noller, H. F. (1987) · Nature · doi:10.1038/327389a0 · Cited by 1,150
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Scorpio, A., & Zhang, Y. (1996) · Nature Medicine · doi:10.1038/nm0696-662 · Cited by 726
Mutation Frequencies and Antibiotic Resistance
Martinez, J. L., & Baquero, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1771-1777.2000 · Cited by 694
The fitness costs of antibiotic resistance mutations
Melnyk, A. H., Wong, A., & Kassen, R. (2015) · Evolutionary Applications · doi:10.1111/eva.12196 · Cited by 689
Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30079-6 · Cited by 684
Self-citationPA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Singh, R., Manjunatha, U., Boshoff, H. I. M., Ha, Y. H., Niyomrattanakit, P., Ledwidge, R., Dowd, C. S., Lee, I. Y., Kim, P., Zhang, L., et al. (2008) · Science · doi:10.1126/science.1164571 · Cited by 628
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
The curious characteristics of pyrazinamide: a review.
Zhang, Y., & Mitchison, D. A. (2003) · PubMed · Cited by 586
Comas, I., Borrell, S., Roetzer, A., Rose, G., Malla, B., Kato-Maeda, M., Galagan, J., Niemann, S., & Gagneux, S. (2012) · Nature Genetics · doi:10.1038/ng.1038 · Cited by 572
Almeida Da Silva, P. E., & Palomino, J. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr173 · Cited by 532
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Shi, W., Zhang, X., Jiang, X., Yuan, H., Lee, J. S., Barry, C. E., Wang, H., Zhang, W., & Zhang, Y. (2011) · Science · doi:10.1126/science.1208813 · Cited by 514
Espinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507
Hartkoorn, R. C., Uplekar, S., & Cole, S. T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00037-14 · Cited by 489
Mechanism of action of and resistance to quinolones
Fàbrega, A., Madurga, S., Giralt, E., & Vila, J. (2009) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2008.00063.x · Cited by 482
Takiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B., Cole, S. T., Jacobs, W. R., & Telenti, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.773 · Cited by 480
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
Telenti, A., Philipp, W. J., Sreevatsan, S., Bernasconi, C., Stockbauer, K. E., Wieles, B., Musser, J. M., & Jacobs, W. R. (1997) · Nature Medicine · doi:10.1038/nm0597-567 · Cited by 472
Ford, C. B., Shah, R. R., Maeda, M. K., Gagneux, S., Murray, M. B., Cohen, T., Johnston, J. C., Gardy, J., Lipsitch, M., & Fortune, S. M. (2013) · Nature Genetics · doi:10.1038/ng.2656 · Cited by 457
Drug Resistance Mechanisms in Mycobacterium tuberculosis
Palomino, J., & Martin, A. (2014) · Antibiotics · doi:10.3390/antibiotics3030317 · Cited by 442
Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
Andries, K., Villellas, C., Coeck, N., Thys, K., Gevers, T., Vranckx, L., Lounis, N., de Jong, B. C., & Koul, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102135 · Cited by 439
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., & Stover, C. K. (1996) · Science · doi:10.1126/science.272.5268.1641 · Cited by 436
Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences
Coll, F., McNerney, R., Preston, M. D., Guerra-Assunção, J. A., Warry, A., Hill-Cawthorne, G., Mallard, K., Nair, M., Miranda, A., Alves, A., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0164-0 · Cited by 420
Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective
Gillespie, S. H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.267-274.2002 · Cited by 412
Campbell, P. J., Morlock, G. P., Sikes, R. D., Dalton, T. L., Metchock, B., Starks, A. M., Hooks, D. P., Cowan, L. S., Plikaytis, B. B., & Posey, J. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01550-10 · Cited by 379
Schaberg, T., Rebhan, K., & Lode, H. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09102026 · Cited by 379
Hazbón, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., García-García, L., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00112-06 · Cited by 374
Somoskovi, A., Parsons, L. M., & Salfinger, M. (2001) · Respiratory Research · doi:10.1186/rr54 · Cited by 373
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
Takayama, K., & Kilburn, J. O. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1493 · Cited by 369
Finken, M., Kirschner, P., Meier, A., Wrede, A., & Böttger, E. C. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01253.x · Cited by 360
Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives
Rattan, A., Kalia, A., & Ahmad, N. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980207 · Cited by 355
Votintseva, A. A., Bradley, P., Pankhurst, L., del Ojo Elias, C., Loose, M., Nilgiriwala, K., Chatterjee, A., Smith, E. G., Sanderson, N., Walker, T. M., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02483-16 · Cited by 344
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
DeBarber, A. E., Mdluli, K., Bosman, M., Bekker, L.-G., & Barry, C. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9677 · Cited by 338
Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., & Graviss, E. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1241-1250.2003 · Cited by 336
The Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics
Vilchèze, C., & Jacobs, Jr. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.111606.122346 · Cited by 335
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations
Sreevatsan, S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L., Jacobs, W. R., Telenti, A., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1677 · Cited by 335
Manjunatha, U. H., Boshoff, H., Dowd, C. S., Zhang, L., Albert, T. J., Norton, J. E., Daniels, L., Dick, T., Pang, S. S., & Barry, C. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508392103 · Cited by 331
Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
Bloemberg, G. V., Keller, P. M., Stucki, D., Trauner, A., Borrell, S., Latshang, T., Coscolla, M., Rothe, T., Hömke, R., Ritter, C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1505196 · Cited by 331
Zaunbrecher, M. A., Sikes, R. D., Metchock, B., Shinnick, T. M., & Posey, J. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907925106 · Cited by 330
Pankhurst, L. J., del Ojo Elias, C., Votintseva, A. A., Walker, T. M., Cole, K., Davies, J., Fermont, J. M., Gascoyne-Binzi, D. M., Kohl, T. A., Kong, C., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00466-x · Cited by 327
Extensively drug-resistant tuberculosis
Jassal, M., & Bishai, W. R. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70260-3 · Cited by 312
Basic Mechanisms of Chemotherapy
Mitchison, D. A. (1979) · Chest · doi:10.1378/chest.76.6.771 · Cited by 301
Okamoto, S., Tamaru, A., Nakajima, C., Nishimura, K., Tanaka, Y., Tokuyama, S., Suzuki, Y., & Ochi, K. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05585.x · Cited by 301
Biogenesis of the mycobacterial cell wall and the site of action of ethambutol
Mikusová, K., Slayden, R. A., Besra, G. S., & Brennan, P. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2484 · Cited by 301
Mutations in Putative Mutator Genes of Mycobacterium tuberculosis Strains of the W-Beijing Family
Ebrahimi-Rad, M., Bifani, P., Martin, C., Kremer, K., Samper, S., Rauzier, J., Kreiswirth, B., Blazquez, J., Jouan, M., van Soolingen, D., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0907.020803 · Cited by 288
Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples
Brown, A. C., Bryant, J. M., Einer-Jensen, K., Holdstock, J., Houniet, D. T., Chan, J. Z. M., Depledge, D. P., Nikolayevskyy, V., Broda, A., Stone, M. J., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00486-15 · Cited by 284
TBResist Global Genome Consortium, Manson, A. L., Cohen, K. A., Abeel, T., Desjardins, C. A., Armstrong, D. T., Barry, C. E., Brand, J., Chapman, S. B., Cho, S.-N., et al. (2017) · Nature Genetics · doi:10.1038/ng.3767 · Cited by 280
Cohen, K. A., Abeel, T., Manson McGuire, A., Desjardins, C. A., Munsamy, V., Shea, T. P., Walker, B. J., Bantubani, N., Almeida, D. V., Alvarado, L., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001880 · Cited by 274
Self-citationZimhony, O., Cox, J. S., Welch, J. T., Vilchèze, C., & Jacobs, W. R. (2000) · Nature Medicine · doi:10.1038/79558 · Cited by 270
Maruri, F., Sterling, T. R., Kaiga, A. W., Blackman, A., van der Heijden, Y. F., Mayer, C., Cambau, E., & Aubry, A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr566 · Cited by 264
A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
Louw, G. E., Warren, R. M., Gey van Pittius, N. C., McEvoy, C. R. E., Van Helden, P. D., & Victor, T. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01577-08 · Cited by 263
Streptomycin Resistance in Pulmonary Tuberculosis
Crofton, J., & Mitchison, D. A. (1948) · BMJ · doi:10.1136/bmj.2.4588.1009 · Cited by 261
MOLECULAR MECHANISMS OF DRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
Blanchard, J. S. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001243 · Cited by 255
Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015
Zhang, Y., & Yew, W.-W. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.15.0389 · Cited by 251
Telenti, A., Imboden, P., Marchesi, F., Schmidheini, T., & Bodmer, T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2054 · Cited by 250
Georghiou, S. B., Magana, M., Garfein, R. S., Catanzaro, D. G., Catanzaro, A., & Rodwell, T. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033275 · Cited by 249
The role of mutators in the emergence of antibiotic-resistant bacteria
Chopra, I., O’Neill, A. J., & Miller, K. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00041-4 · Cited by 246
Dheda, K., Shean, K., Zumla, A., Badri, M., Streicher, E. M., Page-Shipp, L., Willcox, P., John, M.-A., Reubenson, G., Govindasamy, D., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60492-8 · Cited by 246
Pietersen, E., Ignatius, E., Streicher, E. M., Mastrapa, B., Padanilam, X., Pooran, A., Badri, M., Lesosky, M., van Helden, P., Sirgel, F. A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62675-6 · Cited by 246
Aubry, A., Pan, X.-S., Fisher, L. M., Jarlier, V., & Cambau, E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1281-1288.2004 · Cited by 240
Pasipanodya, J. G., Srivastava, S., & Gumbo, T. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis353 · Cited by 239
Machado, D., Couto, I., Perdigão, J., Rodrigues, L., Portugal, I., Baptista, P., Veigas, B., Amaral, L., & Viveiros, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034538 · Cited by 226
de Vos, M., Müller, B., Borrell, S., Black, P. A., van Helden, P. D., Warren, R. M., Gagneux, S., & Victor, T. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01541-12 · Cited by 219
Huitric, E., Verhasselt, P., Koul, A., Andries, K., Hoffner, S., & Andersson, D. I. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01611-09 · Cited by 215
Mechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis
Alangaden, G. J., Kreiswirth, B. N., Aouad, A., Khetarpal, M., Igno, F. R., Moghazeh, S. L., Manavathu, E. K., & Lerner, S. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1295 · Cited by 214
Almeida, D., Ioerger, T., Tyagi, S., Li, S.-Y., Mdluli, K., Andries, K., Grosset, J., Sacchettini, J., & Nuermberger, E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00753-16 · Cited by 209
Safi, H., Lingaraju, S., Amin, A., Kim, S., Jones, M., Holmes, M., McNeil, M., Peterson, S. N., Chatterjee, D., Fleischmann, R., et al. (2013) · Nature Genetics · doi:10.1038/ng.2743 · Cited by 205
Larsen, M. H., Vilchèze, C., Kremer, L., Besra, G. S., Parsons, L., Salfinger, M., Heifets, L., Hazbon, M. H., Alland, D., Sacchettini, J. C., et al. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03162.x · Cited by 202
Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis: Table 1
da Silva, P. E. A., Von Groll, A., Martin, A., & Palomino, J. C. (2011) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2011.00831.x · Cited by 199
Aubry, A., Veziris, N., Cambau, E., Truffot-Pernot, C., Jarlier, V., & Fisher, L. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.104-112.2006 · Cited by 197
Menzies, D., Benedetti, A., Paydar, A., Royce, S., Pai, M., Burman, W., Vernon, A., & Lienhardt, C. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000150 · Cited by 194
Sun, G., Luo, T., Yang, C., Dong, X., Li, J., Zhu, Y., Zheng, H., Tian, W., Wang, S., Barry, C. E., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis601 · Cited by 192
Microevolution of extensively drug-resistant tuberculosis in Russia
Casali, N., Nikolayevskyy, V., Balabanova, Y., Ignatyeva, O., Kontsevaya, I., Harris, S. R., Bentley, S. D., Parkhill, J., Nejentsev, S., Hoffner, S. E., et al. (2012) · Genome Research · doi:10.1101/gr.128678.111 · Cited by 181
Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study
Keshavjee, S., Gelmanova, I. Y., Farmer, P. E., Mishustin, S. P., Strelis, A. K., Andreev, Y. G., Pasechnikov, A. D., Atwood, S., Mukherjee, J. S., Rich, M. L., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61204-0 · Cited by 178
Cheng, S.-J., Thibert, L., Sanchez, T., Heifets, L., & Zhang, Y. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.528-532.2000 · Cited by 175
Rengarajan, J., Sassetti, C. M., Naroditskaya, V., Sloutsky, A., Bloom, B. R., & Rubin, E. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04120.x · Cited by 174
Xu, J., Wang, B., Hu, M., Huo, F., Guo, S., Jing, W., Nuermberger, E. L., & Lu, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00239-17 · Cited by 169
Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
Vilchèze, C., Av‐Gay, Y., Attarian, R., Liu, Z., Hazbón, M. H., Colangeli, R., Chen, B., Liu, W., Alland, D., Sacchettini, J. C., et al. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06365.x · Cited by 168
Ioerger, T. R., Koo, S., No, E.-G., Chen, X., Larsen, M. H., Jacobs, W. R., Pillay, M., Sturm, A. W., & Sacchettini, J. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007778 · Cited by 165
Villellas, C., Coeck, N., Meehan, C. J., Lounis, N., de Jong, B., Rigouts, L., & Andries, K. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw502 · Cited by 162
Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
Pontali, E., Sotgiu, G., D’Ambrosio, L., Centis, R., & Migliori, G. B. (2016) · European Respiratory Journal · doi:10.1183/13993003.01891-2015 · Cited by 159
Lechartier, B., & Cole, S. T. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00395-15 · Cited by 158
Heep, M., Rieger, U., Beck, D., & Lehn, N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1075-1077.2000 · Cited by 153
Traore, H., Fissette, K., Bastian, I., Devleeschouwer, M. J., & Portaels, F. (2000) · PubMed · Cited by 152
Safi, H., Sayers, B., Hazbón, M. H., & Alland, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01486-07 · Cited by 149
Maïga, M., Siddiqui, S., Diallo, S., Diarra, B., Traoré, B., M.S., Y. R. S., Zelazny, A. M., Dembele, B. P. P., Goita, D., Kassambara, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036902 · Cited by 147
A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis
Whitfield, M. G., Soeters, H. M., Warren, R. M., York, T., Sampson, S. L., Streicher, E. M., van Helden, P. D., & Rie, A. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133869 · Cited by 146
Mathys, V., Wintjens, R. T., Lefevre, P., Bertout, J., Singhal, A., Kiass, M., Kurepina, N. E., Wang, X., Mathema, B., Baulard, A. R., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01197-08 · Cited by 143
Zimenkov, D. V., Nosova, E. Y., Kulagina, E. V., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx094 · Cited by 139
First Linezolid-Resistant Clinical Isolates of Mycobacterium tuberculosis
Richter, E., Rüsch–Gerdes, S., & Hillemann, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01113-06 · Cited by 133
Merker, M., Kohl, T. A., Roetzer, A., Trübe, L., Richter, E., Rüsch–Gerdes, S., Fattorini, L., Oggioni, M. R., Cox, H. S., Varaine, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082551 · Cited by 130
Hazbón, M. H., Bobadilla-del-Valle, M., Guerrero, M. I., Basil, M. V., Filliol, I., Cavatore, M., Colangeli, R., Safi, H., Billman‐Jacobe, H., Lavender, C. J., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3794-3802.2005 · Cited by 125
Yimer, G., Ueda, N., Habtewold, A., Amogne, W., Suda, A., Riedel, K., Burhenne, J., Aderaye, G., Lindquist, L., Makonnen, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027810 · Cited by 122
Tang, S., Tan, S., Yao, L., Li, F., Li, L., Guo, X., Liu, Y., Hao, X., Li, Y., Ding, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082943 · Cited by 119
The complex evolution of antibiotic resistance in Mycobacterium tuberculosis
da Fonseca, J. D., Knight, G. M., & McHugh, T. D. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.01.014 · Cited by 113
Tagliani, E., Cabibbe, A. M., Miotto, P., Borroni, E., Toro, J. C., Mansjö, M., Hoffner, S. E., Hillemann, D., Zalutskaya, A., Skrahina, A. M., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01257-15 · Cited by 111
Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates
Gillespie, S. H., Basu, S., Dickens, A. L., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki191 · Cited by 108
Caws, M., Phan, M., Tho, D. Q., Lan, N. T. N., Hoa, D. V., & Farrar, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00330-06 · Cited by 107
Mycobacterial DNA Extraction for Whole-Genome Sequencing from Early Positive Liquid (MGIT) Cultures
Votintseva, A. A., Pankhurst, L. J., Anson, L. W., Morgan, M. R., Gascoyne‐Binzi, D., Walker, T. M., Quan, T. P., Wyllie, D. H., Elías, C. D. O., Wilcox, M. H., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03073-14 · Cited by 104
Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009
Jenkins, H. E., Zignol, M., & Cohen, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022927 · Cited by 103
Clinical value of whole-genome sequencing of Mycobacterium tuberculosis
Takiff, H. E., & Feo, O. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00071-7 · Cited by 101
Shcherbakov, D., Akbergenov, R., Matt, T., Sander, P., Andersson, D. I., & Böttger, E. C. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07218.x · Cited by 100
Shean, K., Streicher, E. M., Pieterson, E., Symons, G., van Zyl-Smit, R. N., Theron, G., Lehloenya, R. J., Padanilam, X., Wilcox, P. D., Victor, T. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063057 · Cited by 99
Theron, G., Peter, J., Richardson, M., Barnard, M., Donegan, S., Warren, R. M., Steingart, K. R., & Dheda, K. U. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010705.pub2 · Cited by 99
Brossier, F., Véziris, N., Truffot-Pernot, C., Jarlier, V., & Sougakoff, W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01030-10 · Cited by 98
Drug Susceptibility ofMycobacterium tuberculosisBeijing Genotype and Association with MDR TB
de Steenwinkel, J. E. M., ten Kate, M. T., de Knegt, G. J., Kremer, K., Aarnoutse, R. E., Boeree, M. J., Verbrugh, H. A., van Soolingen, D., & Bakker‐Woudenberg, I. A. J. M. (2012) · Emerging infectious diseases · doi:10.3201/eid1804.110912 · Cited by 96
Sun, Z., Zhang, J., Zhang, X., Wang, S., Zhang, Y., & Li, C. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.10.014 · Cited by 87
Zhao, F., Wang, X.-D., Erber, L. N., Luo, M., Guo, A.-Z., Yang, S.-S., Gu, J., Turman, B. J., Gao, Y.-R., Li, D., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01775-13 · Cited by 87
The role of delamanid in the treatment of drug-resistant tuberculosis
Sloan, D. J., & Lewis, J. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s71076 · Cited by 86
Trauner, A., Borrell, S., Reither, K., & Gagneux, S. (2014) · Drugs · doi:10.1007/s40265-014-0248-y · Cited by 84
Drug Metabolism and Pharmacokinetics in Malnourished Children
Krishnaswamy, K. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198900171-00006 · Cited by 83
A silent mutation in mabA confers isoniazid resistance on M ycobacterium tuberculosis
Ando, H., Miyoshi‐Akiyama, T., Watanabe, S., & Kirikae, T. (2013) · Molecular Microbiology · doi:10.1111/mmi.12476 · Cited by 80
Villegas, L. A., Otero, L., Sterling, T. R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152933 · Cited by 79
Okoi, C., Anderson, S. T. B., Antonio, M., Mulwa, S. N., Gehre, F., & Adetifa, I. (2017) · Scientific Reports · doi:10.1038/s41598-017-12175-z · Cited by 75
Rueda, J., Realpe, T., Mejía, G. I., Zapata, E. M., Rozo, J. C., Ferro, B. E., & Robledo, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01028-15 · Cited by 70
Manson, A. L., Abeel, T., Galagan, J. E., Sundaramurthi, J. C., Salazar, A., Gehrmann, T., Shanmugam, S. K., Palaniyandi, K., Narayanan, S., Swaminathan, S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix169 · Cited by 68
He, L., Wang, X., Cui, P., Jin, J., Chen, J., Zhang, W., & Zhang, Y. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.12.002 · Cited by 64
Feuerriegel, S., Köser, C. U., Baù, D., Rüsch–Gerdes, S., Summers, D., Archer, J. A. C., Martı́-Renom, M. A., & Niemann, S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05500-11 · Cited by 63
Bactericidal activity of OPC-67683 against drug-tolerant Mycobacterium tuberculosis
Saliu, O. Y., Crismale, C., Schwander, S., & Wallis, R. S. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm291 · Cited by 63
Choi, R., Jeong, B., Koh, W., & Lee, S. (2016) · Annals of Laboratory Medicine · doi:10.3343/alm.2017.37.2.97 · Cited by 61
Saunders, N. J. S. G., Trivedi, U. H., Thomson, M. L., Doig, C., Laurenson, I. F., & Blaxter, M. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.01.003 · Cited by 57
Ando, H., Kitao, T., Miyoshi‐Akiyama, T., Kato, S., Mori, T., & Kirikae, T. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07547.x · Cited by 55
O’Donnell, M. R., Padayatchi, N., Master, I., Osburn, G., & Horsburgh, C. R. (2009) · PubMed · Cited by 54
Self-citationNon- pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?
Werngren, J., Alm, E., & Mansjö, M. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02532-16 · Cited by 53
O’Donnell, M. R., Wolf, A., Werner, L., Horsburgh, C. R., & Padayatchi, N. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000221 · Cited by 49
Self-citationMariam, S. H., Werngren, J., Aronsson, J., Hoffner, S. E., & Andersson, D. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021147 · Cited by 48
Therapeutic drug monitoring: how to improve drug dosage and patient safety in tuberculosis treatment
Sotgiu, G., Alffenaar, J. C., Centis, R., D’Ambrosio, L., Spanevello, A., Piana, A. F., & Migliori, G. B. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.12.001 · Cited by 47
Drug Resistance Evolution of a Mycobacterium tuberculosis Strain from a Noncompliant Patient
Meacci, F., Orrù, G., Iona, E., Giannoni, F., Piersimoni, C., Pozzi, G., Fattorini, L., & Oggioni, M. R. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3114-3120.2005 · Cited by 47
Carette, X., Blondiaux, N., Willery, E., Hoos, S., Lecat‐Guillet, N., Lens, Z., Wohlkönig, A., Wintjens, R. T., Soror, S. H. A., Frénois, F., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1113 · Cited by 46
Cardoso, R. F., Cardoso, M. A., Leite, C. Q. F., Sato, D. N., Mamizuka, E. M., Hirata, R. D. C., de Mello, F. A. F., & Hirata, M. H. (2007) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762007000100009 · Cited by 42
Pandey, B., Grover, S., Tyagi, C., Goyal, S., Jamal, S., Singh, A. P., Kaur, J., & Grover, A. (2016) · Gene · doi:10.1016/j.gene.2016.01.024 · Cited by 41
Dutta, N. K., Pinn, M. L., & Karakousis, P. C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02981-14 · Cited by 36
Reeves, A. Z., Campbell, P., Willby, M. J., & Posey, J. E. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04438-14 · Cited by 32
Tuberculosis In Australia: Bacteriologically confirmed cases and drug resistance, 2010
Lumb, R., Bastian, I., Gilpin, C., Jelfs, P. J., Keehner, T., & Sievers, A. S. (2008) · Communicable Diseases Intelligence · doi:10.33321/cdi.2008.32.2 · Cited by 30
Ho, Y. M., Sun, Y.-J., Wong, S. Y., & Lee, A. S. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00433-09 · Cited by 29
Swaminathan, S., Sundaramurthi, J. C., Palaniappan, A. N., & Narayanan, S. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.08.002 · Cited by 25
Lumb, R., Bastian, I., Crighton, T., et al. (2004) · Communicable Diseases Intelligence · doi:10.33321/cdi.2004.28.51 · Cited by 23
Cited by
Recent updates on drug resistance in Mycobacterium tuberculosis
Singh, R., Dwivedi, S. P., Gaharwar, U. S., Meena, R., Rajamani, P., & Prasad, T. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14478 · Cited by 337
Review and Comparison of Antimicrobial Resistance Gene Databases
Papp, M., & Solymosi, N. (2022) · Antibiotics · doi:10.3390/antibiotics11030339 · Cited by 96
Review and Comparison of Antimicrobial Resistance Gene Databases
Papp, M., & Solymosi, N. (2022) · doi:10.20944/preprints202202.0200.v1 · Cited by 97
Metadata
- Authors
- Dookie, N., Rambaran, S., Padayatchi, N., Mahomed, S., & Naidoo, K.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01-19
- Volume
- 73
- Issue
- 5
- Pages
- 1138-1151
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2794044688
- Cited by
- 346
- References
- 140
- FWCI
- 25.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.